Researchers intrigued by people with hallmarks of Alzheimer’s disease — but none of the symptoms — have probed their brains in the search for a cure. They initially drew samples from the Netherlands .
Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, has released a new Conversations video ...